Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea

European Neurology
R PioltiL Frattola

Abstract

In a pilot study, proglumide, a cholecystokinin receptor antagonist, was administered to 8 patients affected from Huntington's chorea under long-term haloperidol treatment. The effectiveness of haloperidol on chronic symptomatology was reduced by the concomitant administration of proglumide; the latter drug, when administered alone, did not modify the severity of chorea compared to placebo. Possible explanations of these results are discussed, stressing the modulatory role of CCK not only on the dopaminergic, but also on the GABAergic system.

Citations

Sep 7, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·O ZachrissonN Lindefors
Aug 17, 2010·Pharmacology & Therapeutics·Megan J DowieMichelle Glass

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here